The study demonstrated that the M6P-IL10 compound retained the anti-inflammatory and antifibrotic action typical of IL10, the latter indicated by a reduction of collagen type I deposition in a CCl4-induced rat model of experimental fibrosis. Here, IL10 is linked to fibrosis.